149 related articles for article (PubMed ID: 22722333)
1. Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells.
Wang G; Deng Y; Cao X; Lai S; Tong Y; Luo X; Feng Y; Xia X; Gong J; Hu J
Cell Death Differ; 2012 Nov; 19(11):1870-9. PubMed ID: 22722333
[TBL] [Abstract][Full Text] [Related]
2. A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy.
Hu J; Xia X; Cheng A; Wang G; Luo X; Reed MF; Fojo T; Oetting A; Gong J; Yen PM
Mol Cancer Ther; 2008 Dec; 7(12):3719-28. PubMed ID: 19074847
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of N-terminal of p55PIK--regulatory subunit of phosphoinositide-3 kinase--on proliferation of gastric cancer cell line MGC803 and its mechanism].
Sun XJ; Zhao M; Yuan XH; Yu Q; Zheng LM; Fang MJ; Huang CZ
Ai Zheng; 2006 Mar; 25(3):264-8. PubMed ID: 16536976
[TBL] [Abstract][Full Text] [Related]
4. A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis.
Zhu M; Yang H; Chen Z; Xia X; Deng Q; Shen Y
Exp Eye Res; 2020 Oct; 199():108180. PubMed ID: 32777209
[TBL] [Abstract][Full Text] [Related]
5. PI3K stimulates DNA synthesis and cell-cycle progression via its p55PIK regulatory subunit interaction with PCNA.
Wang G; Cao X; Lai S; Luo X; Feng Y; Xia X; Yen PM; Gong J; Hu J
Mol Cancer Ther; 2013 Oct; 12(10):2100-9. PubMed ID: 23939377
[TBL] [Abstract][Full Text] [Related]
6. p55γ functional mimetic peptide N24 blocks vascular proliferative disorders.
Guo J; Xie N; Li G; Zhang Y; Lv F; Guo S; Feng Y; Cao CM; Xiao RP
J Mol Med (Berl); 2015 Oct; 93(10):1107-18. PubMed ID: 25894383
[TBL] [Abstract][Full Text] [Related]
7. Changes in phosphatidylinositol 3-kinase 55 kDa gamma expression and subcellular localization may be caspase 6 dependent in paraquat-induced SH-SY5Y apoptosis.
Zhou Y; Li F; Tian X; Wang B; Ding M; Pang H
Hum Exp Toxicol; 2014 Jul; 33(7):761-71. PubMed ID: 24130211
[TBL] [Abstract][Full Text] [Related]
8. P55PIK Regulates P53-Dependent Apoptosis in Cancer Cells by Interacting with P53 DNA-Specific Domain.
Li C; Li W; Cheng X; Zhang D; Sun X; Zhou J; Zhou Y; Huang Y; Xia X; Ma Q; Su Z
Onco Targets Ther; 2020; 13():5177-5190. PubMed ID: 32606738
[TBL] [Abstract][Full Text] [Related]
9. A cell-permeable peptide inhibitor of p55PIK signaling alleviates suture-induced corneal neovascularization and inflammation.
Huang J; Zhang Y; Lin T; Yin H; Pan Y; Zhu M; Zhang M
Heliyon; 2023 Apr; 9(4):e14869. PubMed ID: 37095989
[TBL] [Abstract][Full Text] [Related]
10. p55PIK deficiency and its NH
Wang T; Du X; Wang Z; Gu Y; Huang Q; Wu J; Zhan Y; Chen J; Xiao C; Xie J
Am J Physiol Lung Cell Mol Physiol; 2021 Jul; 321(1):L159-L173. PubMed ID: 33949204
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.
Ma M; Wang X; Chen X; Cai R; Chen F; Dong W; Yang G; Pang W
RNA Biol; 2017 Mar; 14(3):347-360. PubMed ID: 28085550
[TBL] [Abstract][Full Text] [Related]
12. Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins.
Mothe I; Delahaye L; Filloux C; Pons S; White MF; Van Obberghen E
Mol Endocrinol; 1997 Dec; 11(13):1911-23. PubMed ID: 9415396
[TBL] [Abstract][Full Text] [Related]
13. p55PIK transcriptionally activated by MZF1 promotes colorectal cancer cell proliferation.
Deng Y; Wang J; Wang G; Jin Y; Luo X; Xia X; Gong J; Hu J
Biomed Res Int; 2013; 2013():868131. PubMed ID: 23509792
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the N-terminal end of the p55gamma regulatory subunit of phosphatidylinositol 3-kinase blocks cell cycle progression in gastric carcinoma cells.
Hu J; Liu S; Wang J; Luo X; Gao X; Xia X; Feng Y; Tao D; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ; Gong J
Int J Oncol; 2005 May; 26(5):1321-7. PubMed ID: 15809724
[TBL] [Abstract][Full Text] [Related]
15. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.
Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J
Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973
[TBL] [Abstract][Full Text] [Related]
16. TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity.
Zhong J; Kang J; Wang X; Jiang W; Liao H; Yuan J
Med Oncol; 2015 Apr; 32(4):118. PubMed ID: 25782870
[TBL] [Abstract][Full Text] [Related]
17. Cell-penetrating TAT-FOXO3 fusion proteins induce apoptotic cell death in leukemic cells.
Essafi M; Baudot AD; Mouska X; Cassuto JP; Ticchioni M; Deckert M
Mol Cancer Ther; 2011 Jan; 10(1):37-46. PubMed ID: 21220490
[TBL] [Abstract][Full Text] [Related]
18. Multiple forms of p55PIK, a regulatory subunit of phosphoinositide 3-kinase, are generated by alternative initiation of translation.
Xia X; Serrero G
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):831-7. PubMed ID: 10417350
[TBL] [Abstract][Full Text] [Related]
19. Secretory TAT-peptide-mediated protein transduction of LIF receptor α-chain distal cytoplasmic motifs into human myeloid HL-60 cells.
Sun Q; Xiong J; Lu J; Xu S; Li Y; Zhong XP; Gao GK; Liu HQ
Braz J Med Biol Res; 2012 Oct; 45(10):913-20. PubMed ID: 22714809
[TBL] [Abstract][Full Text] [Related]
20. Transduction of TAT fusion proteins into osteoclasts and osteoblasts.
Dolgilevich S; Zaidi N; Song J; Abe E; Moonga BS; Sun L
Biochem Biophys Res Commun; 2002 Dec; 299(3):505-9. PubMed ID: 12445831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
